Isracann Biosciences Inc. - CEO, Phil Floucault
CEO, Phil Floucault
Source: Cowichan Valley Citizen
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Isracann Bioscience (IPOT) announces that its first shipment of cannabis strains has cleared Israeli customs
  • The three strains shipped are called: Liberty Haze, Hell Monkey, and Grape Stomper
  • Canadian quality cannabis will soon be grown in Israel and available to Israeli customers
  • Isracann engages in the cultivation, manufacturing, distribution, and branding of medical cannabis-based products
  • Isracann Biosciences Inc. (IPOT) opened trading at C$0.045

Isracann Bioscience (IPOT) announces that its first shipment of cannabis strains has cleared Israeli customs and are being raised as mother stock.

“The Israeli market will now have access to premium Canadian high THC genetics,” notes CEO Phil Floucault.

“The three strains we shipped are called: Liberty Haze, Hell Monkey, and Grape Stomper. All three strains have received a positive response from consumers in Canada, and I am looking forward to being able to make them available to the Israeli market.”

The three strains sent were developed as part of United Greeneries’ “Grass Roots” genetics program, which aims to produce novel high THC strains with commercially high yields.

Currently being sold as premium cannabis flower in Canada, the three strains represent some of the top performing genetics in United Greeneries’ catalogue. With the support of United Greeneries and Isracann, all three strains have been integrated into the Intelicanna facility and are being prepared as the initial Israeli mother stock.

Phil Floucault continues, “The planning and preparation by the teams in Canada and Israel made this genetics shipment happen smoothly. The growing teams are now fully engaged and working to expedite the process of scaling to full production. In the near term, Canadian quality cannabis will be grown in Israel and available to Israeli customers. Canadian genetics, Israeli grown.”

Isracann engages in the cultivation, manufacturing, distribution, and branding of medical cannabis-based products.

Isracann Biosciences Inc. (IPOT) opened trading at C$0.045.


More From The Market Herald
Aleafia Health - CEO, Tricia Symmes

" Aleafia Health (TSX:AH) completes TSX review and enters fifth province

Aleafia Health (AH) has completed the TSX delisting review and has satisfied the Toronto Stock Exchange’s requirements for continued listing.

" Cannara Biotech (TSXV:LOVE) reports fourth quarter financial results

Cannara Biotech (LOVE) is reporting its latest round of financial results.

" Halo Collective Inc. (NEO:HALO) increasing Oregon facility production to max capacity

Halo Collective Inc. (HALO) has taken initial steps to increase production to max capacity at its Pistil Point, Oregon Facility.

" The Market Herald’s Weekly Cannabis Report – Nov 25, 2022

High Tide (TSXV:HITI) announced that according to data released by New Cannabis Ventures, the company is now Canada’s top revenue-generating cannabis company.